Please ensure Javascript is enabled for purposes of website accessibility

OrganiGram Starts Temporary Layoffs in Light of the Coronavirus Pandemic

By Prosper Junior Bakiny - Mar 23, 2020 at 11:58AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The cannabis company is reducing its operations to help slow the spread of the disease.

Cannabis company OrganiGram Holdings (OGI -4.63%) recently announced that it was taking further steps to attempt to protect its customers, employees, and their families from the COVID-19 coronavirus.

New Brunswick, Canada-based OrganiGram said it would temporarily lay off many of its workers to facilitate social distancing in its operations. Naturally, that reduction in its workforce will lead to "corresponding production and packaging reductions," which could, in turn, hurt the company's bottom line.

Reducing the amount of contact between people -- aka, social distancing -- is a vital tactic in society's efforts to slow the spread of COVID-19, and other cannabis companies are also doing what they can to avoid being part of the problem. Canopy Growth (CGC -3.54%) recently said it would temporarily close its corporate-owned stores across Canada. 

Red maple leaf surrounded by cannabis leaves

Image Source: Getty Images.

In January, OrganiGram reported stellar financial results for the first quarter of its fiscal 2020. Revenues of 25.2 million Canadian dollars came in significantly ahead of analysts' predictions and represented a 102% year-over-year improvement. OrganiGram also reported adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of CA$4.9 million, after posting an adjusted EBITDA loss of CA$7.9 million during the fourth quarter of its fiscal 2019. OrganiGram's shares soared by more than 30% on the heels of its Q1 earnings report, but the company has now more than given up these gains. Year to date, OrganiGram's shares are down by 31.8%, and given the way the pandemic is impacting the North American economies, things could get much worse for the company -- and for its peers in the cannabis industry -- before they get better. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

OrganiGram Holdings Stock Quote
OrganiGram Holdings
$0.96 (-4.63%) $0.05
Canopy Growth Stock Quote
Canopy Growth
$3.48 (-3.54%) $0.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.